Blood–Brain Barrier‐Penetrating and Lesion‐Targeting Nanoplatforms Inspired by the Pathophysiological Features for Synergistic Ischemic Stroke Therapy
Top Cited Papers
- 22 February 2024
- journal article
- research article
- Published by Wiley in Advanced Materials
- Vol. 36 (21) , e2312897
Abstract
Ischemic stroke is a dreadful vascular disorder that poses enormous threats to the public health. Due to its complicated pathophysiological features, current treatment options after ischemic stroke attack remains unsatisfactory. Insufficient drug delivery to ischemic lesions impeded by the blood–brain barrier (BBB) largely limits the therapeutic efficacy of most anti‐stroke agents. Herein, inspired by the rapid BBB penetrability of 4T1 tumor cells upon their brain metastasis and natural roles of platelet in targeting injured vasculatures, a bio‐derived nanojacket is developed by fusing 4T1 tumor cell membrane with platelet membrane, which further clothes on the surface of paeonol and polymetformin‐loaded liposome to obtain biomimetic nanoplatforms (PP@PCL) for ischemic stroke treatment. The designed PP@PCL could remarkably alleviate ischemia‐reperfusion injury by efficiently targeting ischemic lesion, preventing neuroinflammation, scavenging excess reactive oxygen species (ROS), reprogramming microglia phenotypes, and promoting angiogenesis due to the synergistic therapeutic mechanisms that anchor the pathophysiological characteristics of ischemic stroke. As a result, PP@PCL exerts desirable therapeutic efficacy in injured PC12 neuronal cells and rat model of ischemic stroke, which significantly attenuates neuronal apoptosis, reduces infarct volume, and recovers neurological functions, bringing new insights into exploiting promising treatment strategies for cerebral ischemic stroke management.Keywords
Funding Information
- National Natural Science Foundation of China (32071387, 31872756)
- Six Talent Peaks Project in Jiangsu Province (JY‐079)
This publication has 67 references indexed in Scilit:
- Paeonol Suppresses Neuroinflammatory Responses in LPS-Activated Microglia CellsInflammation, 2016
- Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammationThe Lancet Neurology, 2016
- PolyMetformin combines carrier and anticancer activities for in vivo siRNA deliveryNature Communications, 2016
- pH gradient difference around ischemic brain tissue can serve as a trigger for delivering polyethylene glycol-conjugated urokinase nanogelsJournal of Controlled Release, 2016
- Paeonol pretreatment attenuates cerebral ischemic injury via upregulating expression of pAkt, Nrf2, HO-1 and ameliorating BBB permeability in miceBrain Research Bulletin, 2014
- Improvement of functional recovery by chronic metformin treatment is associated with enhanced alternative activation of microglia/macrophages and increased angiogenesis and neurogenesis following experimental strokeBrain, Behavior, and Immunity, 2014
- Acute metformin preconditioning confers neuroprotection against focal cerebral ischaemia by pre‐activation of AMPK‐dependent autophagyBritish Journal of Pharmacology, 2014
- Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug DeliveryNano Letters, 2014
- Chronic metformin treatment improves post‐stroke angiogenesis and recovery after experimental strokeEuropean Journal of Neuroscience, 2014
- Paeonol Attenuates Microglia-Mediated Inflammation and Oxidative Stress–Induced Neurotoxicity in Rat Primary Microglia and Cortical NeuronsShock, 2012